MARILYN CONLON: Open Payments
NPI 1548373186 · TRAVERSE CITY, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$546 in 16 payments from 7 companies in 2025. Trend: 2023 $330 · 2024 $542 · 2025 $546
Food & beverage: $546
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 9 | $305 |
| E.R. Squibb & Sons, L.L.C. | 1 | $120 |
| Vanda Pharmaceuticals Inc. | 2 | $30 |
| Axsome Therapeutics, Inc. | 1 | $26 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $24 |
| Indivior Inc. | 1 | $21 |
| Orexo US, Inc. | 1 | $21 |
Products named: REXULTI, COBENFY, FANAPT, Auvelity, ABILIFY ASIMTUFII, SUBLOCADE, Zubsolv.
Industry payments across MI — which companies pay providers there.
